Advances in Drug Discovery Processes (including HTE)

This session welcomes abstracts addressing the latest advances in processes that enable drug discovery. Examples would be inclusive of both experimental and computational approaches to library and diversity generation, lead molecule ID, data rich methods for SAR, and subsequent scaling initiatives. Topics may include, but are not limited to, target identification, discovery related processes with molecules small and large, novel platforms for diversity generation, high-throughput screening, computational techniques for retrosynthetic analysis or reaction outcome prediction, methodology development for novel bond formation or access to challenging chemical building blocks, and separation/purification techniques.